Trevi Therapeutics Inc. (TRVI) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Trevi Therapeutics Inc.

NASDAQ: TRVI · Real-Time Price · USD
9.88
0.32 (3.35%)
At close: Oct 03, 2025, 3:59 PM
9.40
-4.86%
After-hours: Oct 03, 2025, 05:47 PM EDT

Trevi Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
34.1M 32.4M 12.59M 36.83M
Short-Term Investments
73.53M 50.57M 107.92M n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
243K 297K 205K 334K
Receivables
532K n/a n/a 241K
Inventory
n/a n/a n/a n/a
Other Current Assets
335K 955K 1.31M n/a
Total Current Assets
109.43M 87.55M 122.62M 37.96M
Property-Plant & Equipment
1.23M 1.56M 194K 184K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
1.47M 1.86M 399K 518K
Total Assets
110.9M 89.4M 123.02M 38.48M
Account Payables
3.41M 1.81M 2.86M 2.85M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
285K 306K 7M 5.83M
Other Current Liabilities
2.25M 1.79M n/a 114K
Total Current Liabilities
10.51M 5.82M 13.4M 12.72M
Long-Term Debt
n/a n/a 2.15M 8.65M
Other Long-Term Liabilities
n/a n/a 3K n/a
Total Long-Term Liabilities
747K 1.03M 2.16M 8.68M
Total Liabilities
11.26M 6.86M 15.56M 21.4M
Total Debt
1.03M 1.34M 9.18M 14.63M
Book Value
99.64M 82.55M 107.46M 17.07M
Book Value Per Share
0.99 0.83 1.66 0.75
Common Stock
94K 68K 60K 29K
Retained Earnings
-287.05M -239.13M -210.07M -180.92M
Comprehensive Income
61K -29K -122K n/a
Shareholders Equity
99.64M 82.55M 107.46M 17.07M
Total Investments
73.53M 50.57M 107.92M n/a